EUVIMEDEUVIMED entdecken
Open Access

Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis

Jay Jiyong Kwak, Seung Won Lee, Nang Kyeong Lee, Jin Yeong Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Yong Joon Kim

JAMA Network Open · 15.05.2026 · 9 (5) · e2613049

DOI: 10.1001/jamanetworkopen.2026.13049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 15.05.2026. Verfasst von Jay Jiyong Kwak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Uveitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Pediatric uveitis is frequently associated with immune-mediated inflammatory diseases (IMIDs); however, population-level estimates of IMID risk and immunosuppressant use are limited, as existing evidence is largely derived from tertiary-center cohorts with substantial referral bias.

Objective

To estimate the incidence and risk of developing IMIDs among children and adolescents newly diagnosed with noninfectious uveitis without a prior history of IMIDs. Design, Setting, and Participants This population-based cohort study includes nationwide health insurance claims data from Korea from January 2008 through February 2024. Participants included children and adolescents younger than 20 years who were newly diagnosed with uveitis in Korea between 2011 and 2022. Data were analyzed from February to November 2025. Exposure Diagnosis of uveitis Main Outcomes and Measures Primary outcomes were the estimated 5-year cumulative incidence of a composite of 13 predefined IMIDs and the age- and sex-adjusted standardized incidence ratios (SIRs) compared with the general pediatric population.

Results

In this cohort study, 27 656 children and adolescents (mean [SD] age, 12.6 [4.8] years; 16 827 males [58.3%]) with incident noninfectious uveitis and no prior IMID diagnosis or immunosuppressant prescription were identified. The estimated 5-year cumulative incidence of composite IMIDs was 8.52% (95% CI, 8.16%-8.87%). The most frequently newly diagnosed IMID following uveitis was ankylosing spondylitis (2.53%; 95% CI, 2.33%-2.73%); however, the distribution of IMIDs differed across age groups. Compared with the general pediatric population, the overall SIR for IMIDs was 6.78 (95% CI, 6.54-7.02). Disease-specific SIRs were the highest for sarcoidosis (444.48; 95% CI, 357.98-551.89), ankylosing spondylitis (68.9; 95% CI, 64.5-73.7), and Behçet disease (66.3; 95% CI, 57.8-76.0). The use of immunosuppressive therapies varied substantially by level of medical care, with a higher estimated 5-year incidence in secondary and tertiary care settings than in primary care settings (8.42%; 95% CI, 7.67%-9.16% vs 0.67%; 95% CI, 0.55%-0.79%; P < .001), along with variation in prescribed agents.

Conclusions

In this cohort study, children and adolescents with uveitis had an approximately 7-fold increased risk of developing IMIDs compared with the general population, with variation in disease patterns and treatment according to demographic and health care factors. These findings highlight the importance of systematic and risk-stratified screening for IMIDs in pediatric patients with uveitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UveitisHumansFemaleChildMaleAdolescentIncidenceRepublic of KoreaCohort StudiesChild, PreschoolImmunosuppressive Agents

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University, Seoul, Republic of Korea.
  • Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.

Zitieren

APA

Kwak, J. J., Lee, S. W., Lee, N. K., Kim, J. Y., Lee, C. S., Byeon, S. H., Kim, S. S., & Kim, Y. J. (2026). Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis. JAMA Network Open, 9(5), e2613049. https://doi.org/10.1001/jamanetworkopen.2026.13049

Vancouver

Kwak JJ, Lee SW, Lee NK, Kim JY, Lee CS, Byeon SH, et al. Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis. JAMA Network Open. 2026;9(5):e2613049. doi:10.1001/jamanetworkopen.2026.13049

BibTeX
@article{Kwak2026,
  author = {Kwak, Jay Jiyong and Lee, Seung Won and Lee, Nang Kyeong and Kim, Jin Yeong and Lee, Christopher Seungkyu and Byeon, Suk Ho and Kim, Sung Soo and Kim, Yong Joon},
  title = {Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {5},
  pages = {e2613049},
  doi = {10.1001/jamanetworkopen.2026.13049}
}
Kostenlos starten →